If women’s health is important to you – don’t miss thisweeks She Leads Biotech!
Did you know that:
In 2025 it’s estimated that almost 21,000women in the US will receive a new diagnosis of ovarian cancer.
A woman’s risk of developing ovarian cancer during her lifetime is about 1-91
Appx half the women diagnosed with ovarian cancer are 63 years or older
And there’s no standard screening available for early detection!
That’s why I’m so thrilled to have as my guest this week Oriana Papin Zoghbi, CEO of AOA Diagnostics—a company pioneering early detection solutions for ovarian cancer.
Ovarian cancer has long been called the "silentkiller", but Oriana and her team are working to change that. She has raised nearly $30 million in funding, built a world-class team, and is breaking new ground in diagnostics. In this episode, Oriana gets candid about:
💡 The challenges of leading a startup in healthcare innovation
💡 Why failure isn’t the end—it’s part of growth
💡 The importance of hiring smart, adaptable people
💡 Why investment in diagnostics is critical for saving lives
💡 Her vision for the future of women’s health beyond ovarian cancer
Chapters
00:00Introduction and Background
01:48Journey into Women's Health Diagnostics
04:20Focus on Ovarian Cancer Detection
08:22Company Growth and Team Dynamics
10:16Leadership and Company Culture
23:41Advice for Aspiring CEOs
25:23Embracing Failure as a Learning Tool
28:40Future Aspirations and Diversification